Manuscript
Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study
Laura M. Güdemann et al.
The Lancet Regional Health – Europe 2026;61:101547
Manuscript
Estimating the risk of cardiovascular outcomes and all-cause mortality in individuals with type 2 diabetes: Validation of the UKPDS Outcomes Model using TECOS and EXSCEL data
Coleman RL et al.
Diabetes Obes Metab. 2026;28:1068-1075
Manuscript
The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review
Ashni Goshrani et al.
Diabetes Care 2026;49:197-210
Manuscript
Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy
Eberhard Standl et al.
Cardiovasc Diabetol. 2025;14:441
Manuscript
International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL
Philip M Clarke et al.
Diabetes Care 2025;48:1925-1931
Manuscript
Utilization of proteomic surrogates for early detection of unexpected drug benefits
Jessica Chadwick et al.
J Clin Pharmacol. 2025;65:1460-1473